Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva
Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva |
[31-March-2020] |
WASHINGTON, March 31, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment. ABOUT DANAHER
SOURCE Danaher Corporation | ||
Company Codes: NYSE:DHR, NYSE:GE |
© 2020 PR Newswire. All Rights Reserved.
BREAKING NEWS: Herbal Works Inc. Searching for Brand Social Media Influencer and Social Media Brand Ambassador

